Search Results
Peiwen Wu
Peiwen Wu
Department of Radiation Oncology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China
Search for other papers by Peiwen Wu in
Google Scholar
PubMed
Search for other papers by Peiwen Wu in
Google Scholar
PubMed
Dongjie He
Dongjie He
Department of Radiation Oncology, Tangdu Hospital, the Second Affiliated Hospital of Air Force Medical University, Xi’an, China
Search for other papers by Dongjie He in
Google Scholar
PubMed
Search for other papers by Dongjie He in
Google Scholar
PubMed
Hao Chang
Hao Chang
Department of Radiation Oncology, Tangdu Hospital, the Second Affiliated Hospital of Air Force Medical University, Xi’an, China
Search for other papers by Hao Chang in
Google Scholar
PubMed
Search for other papers by Hao Chang in
Google Scholar
PubMed
Xiaozhi Zhang
Xiaozhi Zhang
Department of Radiation Oncology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China
Search for other papers by Xiaozhi Zhang in
Google Scholar
PubMed
Search for other papers by Xiaozhi Zhang in
Google Scholar
PubMed
features, including sex, age, grade, and the primary tumor site may also significantly influence the prognosis ( 12 ). To the best of our knowledge, only a few studies have used nomograms to predict the prognosis of all patients with NETs ( 13 , 14 , 15
Mark J C van Treijen
Mark J C van Treijen
Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute, University Medical Center Utrecht, Utrecht, The Netherlands
Search for other papers by Mark J C van Treijen in
Google Scholar
PubMed
Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute, University Medical Center Utrecht, Utrecht, The Netherlands
Search for other papers by Mark J C van Treijen in
Google Scholar
PubMed
Catharina M Korse
Catharina M Korse
Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute, University Medical Center Utrecht, Utrecht, The Netherlands
Department of Clinical Chemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Search for other papers by Catharina M Korse in
Google Scholar
PubMed
Department of Clinical Chemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Search for other papers by Catharina M Korse in
Google Scholar
PubMed
Wieke H Verbeek
Wieke H Verbeek
Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute, University Medical Center Utrecht, Utrecht, The Netherlands
Department of Gastroenterology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Search for other papers by Wieke H Verbeek in
Google Scholar
PubMed
Department of Gastroenterology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Search for other papers by Wieke H Verbeek in
Google Scholar
PubMed
Margot E T Tesselaar
Margot E T Tesselaar
Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute, University Medical Center Utrecht, Utrecht, The Netherlands
Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Search for other papers by Margot E T Tesselaar in
Google Scholar
PubMed
Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Search for other papers by Margot E T Tesselaar in
Google Scholar
PubMed
Gerlof D Valk
Gerlof D Valk
Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute, University Medical Center Utrecht, Utrecht, The Netherlands
Search for other papers by Gerlof D Valk in
Google Scholar
PubMed
Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute, University Medical Center Utrecht, Utrecht, The Netherlands
Search for other papers by Gerlof D Valk in
Google Scholar
PubMed
patients ( 6 ). Multiple nomograms for NETs of various origins (rectal, small intestine, gastric, enteropancreatic) have been developed to predict treatment efficacy or overall survival but a measure of the underlying tumor biology that reflects tumor
Malgorzata Fuksiewicz
Malgorzata Fuksiewicz
Laboratory of Tumor Markers, Department of Pathology and Laboratory Diagnostics, The Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
Search for other papers by Malgorzata Fuksiewicz in
Google Scholar
PubMed
Search for other papers by Malgorzata Fuksiewicz in
Google Scholar
PubMed
Maria Kowalska
Maria Kowalska
Laboratory of Tumor Markers, Department of Pathology and Laboratory Diagnostics, The Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
Search for other papers by Maria Kowalska in
Google Scholar
PubMed
Search for other papers by Maria Kowalska in
Google Scholar
PubMed
Agnieszka Kolasinska-Cwikla
Agnieszka Kolasinska-Cwikla
Department of Oncology and Radiotherapy, The Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
Search for other papers by Agnieszka Kolasinska-Cwikla in
Google Scholar
PubMed
Search for other papers by Agnieszka Kolasinska-Cwikla in
Google Scholar
PubMed
Beata Kotowicz
Beata Kotowicz
Laboratory of Tumor Markers, Department of Pathology and Laboratory Diagnostics, The Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
Search for other papers by Beata Kotowicz in
Google Scholar
PubMed
Search for other papers by Beata Kotowicz in
Google Scholar
PubMed
treated with somatostatin analogues . Endokrynologia Polska 2021 72 308 – 318 . ( https://doi.org/10.5603/EP.a2021.0060 ) 23 Li Y Wu ZQ Xu Q Goyal H Xu HG . Development and validation of novel nomograms using serum tumor markers for the
